Search Results 471-480 of 16063 for Residual
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
... residual nonhematologic toxicity from prior therapies that has not resolved to ≤ Grade 1 (Note: Grade 2 residual alopecia is not an exclusion);. - ...
The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Through her research, Dr. Kinney hopes to improve the functional status of patients who have suffered strokes or who have residual functional impairments ...
... residual colon/rectum/pouch as the primary disease site. Transforming Healthcare and Outcomes for Children with Inflammatory Bowel Disease. La Crosse, Wis ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
- To evaluate residual effect in follow up. - To evaluate the safety of dupilumab in patients with bilateral NP. - To evaluate functional dupilumab ...
The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and help develop ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.